{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:08:33Z","timestamp":1794258513952,"version":"4.9.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.euroneuro.2022.11.008","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T21:04:18Z","timestamp":1669928658000},"page":"22-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials"],"prefix":"10.1016","volume":"67","author":[{"given":"Che-Yin","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hen","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0114-102X","authenticated-orcid":false,"given":"Mei-Chih Meg","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Wai","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9346-6886","authenticated-orcid":false,"given":"El-Wui","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2022.11.008_bib0001","doi-asserted-by":"crossref","first-page":"65","DOI":"10.9740\/mhc.n190091","article-title":"Off-label use of atypical antipsychotic agents for treatment of insomnia","volume":"4","author":"Anna K Morin","year":"2014","journal-title":"Mental Health Clin."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2146\/ajhp130221","article-title":"Quetiapine for insomnia: a review of the literature","volume":"71","author":"Anderson","year":"2014","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0003","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S1461145709990423","article-title":"Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study","volume":"13","author":"Bandelow","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0004","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4088\/JCP.08m04629","article-title":"Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study","volume":"70","author":"Bauer","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2010.06.031","article-title":"Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study","volume":"128","author":"Bortnick","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0006","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00213-013-3422-0","article-title":"Quetiapine extended-release (Seroquel-XR) versus amitriptyline monotherapy for treating patients with fibromyalgia: a 16-week, randomized, flexible-dose, open-label trial","volume":"231","author":"Calandre","year":"2014","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0007","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/acps.12794","article-title":"Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine","volume":"136","author":"Castberg","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0008","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00213-003-1759-5","article-title":"Sleep-promoting properties of quetiapine in healthy subjects","volume":"174","author":"Cohrs","year":"2004","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0009","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4088\/JCP.08m04592","article-title":"Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study","volume":"70","author":"Cutler","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0010","article-title":"Quetiapine is not a sleeping pill","volume":"139","author":"Debernard","year":"2019","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0011","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1055\/a-1525-2820","article-title":"Effect of quetiapine, from low to high dose, on weight and metabolic traits: results from a prospective cohort study","volume":"54","author":"Dubath","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0012","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.3390\/jcm9103288","article-title":"Effects of age, drug dose, and sampling time on salivary levels of olanzapine, quetiapine, and their metabolites","volume":"9","author":"Dziurkowska","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0013","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S1461145710000015","article-title":"Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study","volume":"13","author":"El-Khalili","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0014","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/YIC.0b013e328301a74c","article-title":"A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder","volume":"23","author":"Garakani","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0269881116681399","article-title":"Low doses of mirtazapine or quetiapine for transient insomnia: a randomised, double-blind, crossover, placebo-controlled trial","volume":"31","author":"Karsten","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0016","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jagp.2013.01.010","article-title":"Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder","volume":"21","author":"Katila","year":"2013","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0017","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/YIC.0b013e32833e34d9","article-title":"Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: A long-term, randomized, placebo-controlled trial","volume":"26","author":"Katzman","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0018","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.9778\/cmajo.20170145","article-title":"The lesser of two evils: a qualitative study of quetiapine prescribing by family physicians","volume":"6","author":"Kelly","year":"2018","journal-title":"CMAJ Open"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0019","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/JCP.0b013e318224864d","article-title":"A randomized, double-blind study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder","volume":"31","author":"Khan","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0020","first-page":"28","article-title":"Comorbid insomnia and psychiatric disorders: an update","volume":"15","author":"Khurshid","year":"2018","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0022","first-page":"759","article-title":"Pharmacological treatment of insomnia","volume":"40","author":"Lie","year":"2015","journal-title":"P. T."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0023","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/da.20740","article-title":"Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial","volume":"27","author":"Liebowitz","year":"2010","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0024","doi-asserted-by":"crossref","first-page":"e17071","DOI":"10.2196\/17071","article-title":"Temporal associations of daily changes in sleep and depression core symptoms in patients suffering from major depressive disorder: idiographic time-series analysis","volume":"7","author":"Lorenz","year":"2020","journal-title":"JMIR Ment Health"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0025","series-title":"StatPearls Publishing Copyright \u00a9 2022","author":"Maan","year":"2022"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0026","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2147\/DDDT.S45575","article-title":"Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial","volume":"7","author":"Maneeton","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0027","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/YIC.0b013e32834d9f49","article-title":"Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study","volume":"27","author":"Merideth","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0028","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/gps.3867","article-title":"Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder","volume":"28","author":"Mezhebovsky","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0029","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3949\/ccjm.88a.20031","article-title":"Quetiapine for primary insomnia: consider the risks","volume":"88","author":"Modesto-Lowe","year":"2021","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0030","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"134","author":"Page","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0031","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/nedt.2007.3.2.219","article-title":"Quetiapine in the treatment of schizophrenia and related disorders","volume":"3","author":"Riedel","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0032","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/JCP.0b013e318267b8ca","article-title":"Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial","volume":"32","author":"Potvin","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0033","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/0269881115626336","article-title":"Effects of short-term quetiapine treatment on emotional processing, sleep and circadian rhythms","volume":"30","author":"Rock","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0034","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.5664\/jcsm.26929","article-title":"Insomnia: definition, prevalence, etiology, and consequences","volume":"3","author":"Roth","year":"2007","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0035","series-title":"Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","author":"Stahl","year":"2021"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0036","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2147\/NDT.S160742","article-title":"Insomnia in hospitalized psychiatric patients: prevalence and associated factors","volume":"14","author":"Talih","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0037","first-page":"729","article-title":"Quetiapine for primary insomnia: a double blind, randomized controlled trial","volume":"93","author":"Tassniyom","year":"2010","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0038","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-017-4763-x","article-title":"Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-na\u00efve patients with a first-episode of non-affective psychosis","volume":"235","author":"V\u00e1zquez-Bourgon","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0039","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/NDT.S50248","article-title":"A randomized, double-blind study of the efficacy and tolerability of extended-release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder","volume":"10","author":"Wang","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0041","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S1092852900020307","article-title":"Extended release quetiapine fumarate monotherapy for major depressive disorder: Results of a double-blind, randomized, placebo-controlled study","volume":"14","author":"Weisler","year":"2009","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0042","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1345\/aph.1L320","article-title":"Effects of quetiapine on sleep in nonpsychiatric and psychiatric conditions","volume":"43","author":"Wine","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.euroneuro.2022.11.008_bib0043","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/YIC.0b013e3283430a0e","article-title":"Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: a systematic review of the placebo-controlled monotherapy and add-on trials","volume":"26","author":"Zhornitsky","year":"2011","journal-title":"Int. Clin. Psychopharmacol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22008987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X22008987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:04:57Z","timestamp":1760378697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X22008987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":42,"alternative-id":["S0924977X22008987"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.11.008","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2022.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}